Exelixis Patents – Key Insights and Stats

Exelixis has a total of 3188 patents globally, out of which 1180 have been granted. Of these 3188 patents, more than 40% patents are active. The USA is where Exelixis has filed the maximum number of patents, followed by Australia and Japan. Parallelly, the USA seems to be the main focused R&D center of Exelixis.

Exelixis was founded in the year 1994. The firm is a genomics-based drug discovery company and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration for cancer.

Do read about some of the most popular patents of Exelixis which have been covered by us in this article and also you can find Exelixis patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Exelixis patent portfolio.

How many patents does Exelixis have?

Exelixis has a total of 3188 patents globally. These patents belong to 443 unique patent families. Out of 3188 patents, 1283 patents are active.

How Many Patents did Exelixis File Every Year?

Exelixis Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantExelixis Applications FiledExelixis Patents Granted
20223272
20219968
20208646
201911470
20187974
20175773
20165759
201510155
2014110126
2013114141
201222094
2011249124

How many Exelixis patents are Alive/Dead?

Worldwide Patents

Exelixis Patent Portfolio

How Many Patents did Exelixis File in Different Countries?

Exelixis Worldwide Patent Filing

Countries in which Exelixis Filed Patents

CountryPatents
United States Of America407
Australia296
Japan273
Europe255
Canada182
Hong Kong (S.A.R.)125
China111
Korea (South)86
Germany75
Mexico74
Taiwan68
Israel63
India61
Brazil60
Eurasia54
South Africa51
New Zealand51
Singapore43
Spain42
Austria38
Argentina36
Norway23
Poland20
Denmark19
Indonesia17
Portugal17
Viet Nam16
Costa Rica16
Philippines16
Malaysia15

 

Where are Research Centres of Exelixis Patents Located?

R&D Centres of Exelixis

10 Best Exelixis Patents

US6511824B1 is the most popular patent in the Exelixis portfolio. It has received 470 citations so far from companies like Diversa Corporation, Verenium Corporation, and Novozymes.

Below is the list of 10 most cited patents of Exelixis:

Publication NumberCitation Count
US6511824B1470
US6515109B1456
WO2006071819A1221
WO2003059884A1212
WO2008073825A1198
WO2008005538A2195
WO2003099821A1175
WO2006108059A1159
WO2008112913A1151
WO2008076415A1148

What are Exelixis key innovation segments?

What Technologies are Covered by Exelixis?

The chart below distributes patents filed by Exelixis in different countries on the basis of the technology protected in patents. It also represents the markets where Exelixis thinks it’s important to protect particular technology inventions.

R&D Focus: How has Exelixis search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Exelixis?

Related Articles

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.